Bartholomew Lab

Research focus

NIH R01 · 2025

Project ACCESS: Advancing Access to HIV/HCV Testing Through Transformation in Syringe Services Programs: A Cluster Randomized Trial

The National HIV Strategy encourages expansion of HIV testing to community health settings, emphasizing it is critical that all people, particularly groups like people who inject drugs (PWID), know their HIV status for rapid initiation of HIV treatment or potential initiation of PrEP. Despite recommendations from CDC that PWID be tested for HIV every year, only 55% report receiving an HIV test in the previous 12 months. Injection drug use (IDU) continues to be a leading cause of HIV infection with 11% of new HIV infections and 66% acute HCV infections attributable to IDU in 2020. In recent years, there has been a national increase in IDU-associated HIV and hepatitis C (HCV) outbreaks,…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.